Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00145990 · ClinicalTrials.gov registry record · NA
The Impact of Dosimeter on Measurement of Airway Responsiveness to Methacholine
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00145990 is a NA study that has completed, run by University of Florida. The registered enrollment target is 12 participants.
The verdict
NCT00145990, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
To determine whether there is a difference in two different breathing tests used to detect asthma. Hypothesis: The Digidoser delivers less methacholine to the airways and will result in a higher PC20 than the value determined by the Rosenthal Dosimeter.
Interventions
- DRUG methacholine
- DEVICE KoKo Digidoser
- DEVICE Rosethal Dosimeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2005-09 |
| Est. Completion | 2005-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00145990
The ClinicalTrials.gov registry entry for NCT00145990 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which methacholine is the first listed.
NCT00145990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00145990 about?
NCT00145990 is a clinical study titled "The Impact of Dosimeter on Measurement of Airway Responsiveness to Methacholine". To determine whether there is a difference in two different breathing tests used to detect asthma. Hypothesis: The Digidoser delivers less methacholine to the airways and will result in a higher PC20 than the value determined by the Rosenthal Dosimeter.
What is the current status of trial NCT00145990?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2005-09. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00145990?
The interventions under investigation include: methacholine (DRUG), KoKo Digidoser (DEVICE), Rosethal Dosimeter (DEVICE).
Who is sponsoring clinical trial NCT00145990?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.